Dear all,
I would like to draw your attention to BICEPS Marie Curie Sklodowska doctoral program, where we have 16 PhD positions across the following institutions across Europe: German Center for Neurodegenerative Diseases (DZNE) Bayer metaSysX GmbH University of Groningen Aarhus University University of Athens University of Belgrade Anacalypsis Therapeutics Sulfateq B.V. H. Lundbeck A/S University of Oxford Suleyman Demirel University Semical Biosurgery
Several positions are focusing on bioinformatics and there are few also dealing with text. (e.g. Bayer one).
You can find positions here: https://euraxess.ec.europa.eu/jobs/search?f%5B0%5D=offer_type%3Ajob_offer&am...
*Beyond neuroInflammation: new Concepts to Elucidate the peripheral immune system's vital role in Parkinson's disease*
Decades of research into Parkinson's disease (PD) have fallen short in fully comprehending its mechanisms, leaving us without a cure. Current treatments merely alleviate symptoms temporarily, but are unable to impede the progression of the disease. Clearly, PD research has hit a wall, and new approaches are needed.
Recent discoveries of the involvement of the peripheral immune system in PD have sparked a groundbreaking proposition by BICEPS: PD must be considered a systemic disease with an immune response involving both brain and periphery. Thus, to revolutionize PD research, we must shift away from the neuro-centric approach of past decades and extend our focus to studying the immune system outside the brain. Furthermore, recent advancements, such as systems biology and artificial intelligence (AI)-driven data mining, diagnosis, and drug development, hold significant promise for advancing PD research. Therefore, BICEPS is uniting PD researchers, immunologists, and experts in AI and systems biology from leading European academic institutions, startup companies, and established pharmaceutical firms into a unique consortium. The primary objective is to train a new generation of PD researchers with interdisciplinary expertise in these fields.
This ambitious goal will be realized through an intensive training program that encompasses cutting-edge methodologies, encourages innovation, nurtures transferable skills, and provides immersive, hands-on research experiences. Thereby, the BICEPS network aims to shape the future of PD research by adopting a fresh perspective and expediting the development of diagnostics and therapies for PD, with a particular focus on the immune system.
Best regards, Dr Nikola Milosevic